Battle of the Biotech's: Judged By Musicians

  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

Battle of the Biotechs: Judged by Musicians

A pitch competition to help jumpstart crowdfunding for biotech campaigns on the music beats cancer platform.

Cash prizes have been generously supported by our partnered musicians who participated in the #MusicBeatsCancer Challenge*

OUR CONTESTANTS

Knowledge Pharmaceuticals
$5,000 Raised
20% Goal
This Campaign expires on Jan 17th, 2023

by Aphios International

This campaign expired on November 1st, 2021.

by IES Life Sciences

This campaign expired on May 31st, 2021.

T-Cell Therapy: A New Standard of Care for Fighting Cancer and Covid-19

by Geneius Biotechnology, Inc.

This campaign expired on June 30th, 2020.

by IES Life Sciences

This campaign expired on June 18th, 2019.

by Otomagnetics

This campaign expired on May 30th, 2018.

by InvivoSciences

This campaign expired on March 8th, 2018.

BioSapien Inc.
$5,100 Raised
20% Goal
This Campaign expires on Jan 17th, 2023

by Aphios International

This campaign expired on November 1st, 2021.

by IES Life Sciences

This campaign expired on May 31st, 2021.

T-Cell Therapy: A New Standard of Care for Fighting Cancer and Covid-19

by Geneius Biotechnology, Inc.

This campaign expired on June 30th, 2020.

by IES Life Sciences

This campaign expired on June 18th, 2019.

by Otomagnetics

This campaign expired on May 30th, 2018.

by InvivoSciences

This campaign expired on March 8th, 2018.

Pulmostics Limited
$10,925 Raised
44% Goal
This Campaign expires on Jan 17th, 2023

by Aphios International

This campaign expired on November 1st, 2021.

by IES Life Sciences

This campaign expired on May 31st, 2021.

T-Cell Therapy: A New Standard of Care for Fighting Cancer and Covid-19

by Geneius Biotechnology, Inc.

This campaign expired on June 30th, 2020.

by IES Life Sciences

This campaign expired on June 18th, 2019.

by Otomagnetics

This campaign expired on May 30th, 2018.

by InvivoSciences

This campaign expired on March 8th, 2018.